OTC Markets OTCPK - Delayed Quote USD

Lonza Group AG (LZAGY)

72.86

-0.03

(-0.04%)

At close: May 2 at 4:00:00 PM EDT

Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Lonza Group Ag (LZAGY) have performed compared to their sector so far this year.

Zacks 25 days ago

BAYN.DE

LZAGY
-0.04%
Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know

Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks 26 days ago

LZAGY
-0.04%
Ethris and Lonza to develop mRNA vaccines for respiratory conditions

The collaboration focuses on creating spray-dried formulations of vaccines tailored for mucosal delivery.

Pharmaceutical Technology 27 days ago

LZAGY
-0.04%
Health Care Roundup: Market Talk

Find insight on Hims & Hers, U.K. pharmaceutical stocks, Novo Nordisk, AstraZeneca and more in the latest Market Talks covering the Health Care sector.

The Wall Street Journal last month

LZAGF
+5.71%

LZAGY
-0.04%

SGFEF
Lonza Group Ltd (LZAGF) (FY 2024) Earnings Call Highlights: Steady Revenue and Strategic Growth ...

Lonza Group Ltd (LZAGF) reports stable revenue, robust cash flow, and outlines ambitious growth plans for 2025 amidst market challenges.

GuruFocus.com 3 months ago

LZAGY
-0.04%
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy

The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is expecting strong interest for it.

Pharmaceutical Technology 3 months ago

LZAGY
-0.04%
Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe

Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.

Pharmaceutical Technology 3 months ago

LZAGY
-0.04%
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology

Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs), today announced that Boehringer has licensed Synaffix's ADC technology. This new partnership significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company's aim of transforming the lives of people with cancer.

PR Newswire 3 months ago

LZAGF
+5.71%

LZAGY
-0.04%
Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology

Synaffix B.V. ("Synaffix"), a Lonza company (SWX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced that it has licensed its ADC technology to Mitsubishi Tanabe Pharma Corporation ("MTPC"), the pharma arm of Mitsubishi Chemical Group ("MCG").

PR Newswire 3 months ago

LZAGF
+5.71%

LZAGY
-0.04%
NVST or LZAGY: Which Is the Better Value Stock Right Now?

NVST vs. LZAGY: Which Stock Is the Better Value Option?

Zacks 3 months ago

LZAGY
-0.04%

NVST
New Strong Sell Stocks for December 23rd

CENTA, IDEXY and LZAGY have been added to the Zacks Rank #5 (Strong Sell) List on December 23, 2024.

Zacks 4 months ago

CENTA

LZAGY
-0.04%
Padlock investors sue Bristol Myers; Dietmar Berger is Gilead’s new CMO

Padlock Therapeutics investors accused Bristol Myers of avoiding making milestone payments promised under a 2016 deal. Elsewhere, Gilead CEO Daniel O’Day hired Berger away from Sanofi.

BioPharma Dive 4 months ago

LZAGY
-0.04%
Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion

Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that it has entered into a licensing agreement with Elevation Oncology, Inc., an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.

PR Newswire 4 months ago

LZAGF
+5.71%

LZAGY
-0.04%
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced the nomination of EO-1022 as its HER3 ADC development candidate. EO-1022 is currently progressing through preclinical development, and Elevation Oncology expects to file an investigational new drug (IND) application in 2026.

PR Newswire 4 months ago

LZAGF
+5.71%

LZAGY
-0.04%

ELEV
Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

Synaffix B.V. ("Synaffix"), a Lonza company (SWX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced that it has licensed its ADC technology to BigHat Biosciences, Inc. ("BigHat"). BigHat will combine Synaffix technology with its world-class ML antibody design platform for the development of a new ADC pipeline program.

PR Newswire 5 months ago

LZAGF
+5.71%

LZAGY
-0.04%
Lonza Group AG (LZAGY): Among UBS’ Top Tech Based Disruptive Stocks For 2030

We recently compiled a list of the UBS’ Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks. In this article, we are going to take a look at where Lonza Group AG (OTC:LZAGY) stands against the other tech based disruptive stocks. When it comes to investing and making massive gains on the stock market, disruption […]

Insider Monkey 6 months ago

LZAGY
-0.04%
AHCO or LZAGY: Which Is the Better Value Stock Right Now?

AHCO vs. LZAGY: Which Stock Is the Better Value Option?

Zacks 6 months ago

LZAGY
-0.04%

AHCO
AHCO vs. LZAGY: Which Stock Is the Better Value Option?

AHCO vs. LZAGY: Which Stock Is the Better Value Option?

Zacks 6 months ago

LZAGY
-0.04%

AHCO
All You Need to Know About Lonza Group (LZAGY) Rating Upgrade to Strong Buy

Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks 7 months ago

LZAGY
-0.04%
ESLOY or LZAGY: Which Is the Better Value Stock Right Now?

ESLOY vs. LZAGY: Which Stock Is the Better Value Option?

Zacks 9 months ago

LZAGY
-0.04%

ESLOY
-0.51%

Performance Overview

Return	LZAGY	MSCI WORLD (^990100-USD-STRD)
YTD	+22.83%	+0.14%
1-Year	+27.92%	+10.79%
3-Year	+26.88%	+30.01%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Lonza Group AG (LZAGY)

Are Medical Stocks Lagging Bayer (BAYRY) This Year?

Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know

Ethris and Lonza to develop mRNA vaccines for respiratory conditions

Health Care Roundup: Market Talk

Lonza Group Ltd (LZAGF) (FY 2024) Earnings Call Highlights: Steady Revenue and Strategic Growth ...

JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy

Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe

Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology

Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology

NVST or LZAGY: Which Is the Better Value Stock Right Now?

New Strong Sell Stocks for December 23rd

Padlock investors sue Bristol Myers; Dietmar Berger is Gilead’s new CMO

Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

Lonza Group AG (LZAGY): Among UBS’ Top Tech Based Disruptive Stocks For 2030

AHCO or LZAGY: Which Is the Better Value Stock Right Now?

AHCO vs. LZAGY: Which Stock Is the Better Value Option?

All You Need to Know About Lonza Group (LZAGY) Rating Upgrade to Strong Buy

ESLOY or LZAGY: Which Is the Better Value Stock Right Now?

Performance Overview